Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Express Scripts Holding Co. (NASDAQ: ESRX).

Full DD Report for ESRX

You must become a subscriber to view this report.


Recent News from (NASDAQ: ESRX)

Inside Rx Prescription Savings Program Marks First Anniversary By Achieving $100 Million Savings Milestone
FRANKLIN LAKES, N.J. , May 16, 2018 /PRNewswire/ -- In just one year, customers of the Inside Rx® prescription savings program collectively have saved $100 million on their medications. Inside Rx, launched by Express Scripts (NASDAQ:ESRX) in May of 2017, is celebrating its fir...
Source: PR Newswire
Date: May, 16 2018 11:13
Glenview added Express Scripts, exited Apple in Q1
Larry Robbins and Mark Horowitz's Glenview Capital discloses the addition of Express Scripts (NASDAQ: ESRX ) to its investments while exiting Apple (NASDAQ: AAPL ) in Q1, according to its 13F filing . More news on: Express Scripts, Inc., Apple Inc., T-Mobile US, Inc., Read more ...
Source: SeekingAlpha
Date: May, 15 2018 17:11
Tracking Seth Klarman's Baupost Group Holdings - Q1 2018 Update
This article is part of a series that provide an ongoing analysis of the changes made to Baupost Group's 13F stock portfolio on a quarterly basis. It is based on Klarman’s regulatory 13F Form filed on 05/14/2018. Please visit our Tracking Seth Klarman’s Baupost Group Holdings ...
Source: SeekingAlpha
Date: May, 15 2018 10:33
Biotechs Emerge Unscathed And Ready To Go!
Biotech Pulse Biotechs have a pulse now, and it's beginning to beat a little harder! As President Trump on Friday, May 11, delivered a blueprint, American Patients First , to lower drug prices the early indications appear to be that the biotech and pharmaceutical industries have jumped th...
Source: SeekingAlpha
Date: May, 15 2018 08:28
Expanding Medicare drug price negotiation?
The Trump administration is weighing expanding Medicare's ability to negotiate drug costs, according to Health and Human Services Secretary Alex Azar, by giving private payers a role in setting the price of medicines. More news on: CVS Health Corporation, Rite Aid Corporation, Walgreens ...
Source: SeekingAlpha
Date: May, 15 2018 05:09
Value SuperScreen Deployed
Introduction In the conclusion of my most recent article, " Value SuperScreen Vs. The S&P 500 ", I discuss a bit of my reservations with the composition of the VSS Portfolio as it sat at that moment, namely, that a few stocks were included which I felt would ultimately not make the cut. ...
Source: SeekingAlpha
Date: May, 14 2018 08:45
Express Scripts and CVS among those gaining after Trump speech
"President Trump rightly recognizes drug companies charge way too much, and their prices need to come down," says Express Scripts ( ESRX +3.7% ) following today's speech. More news on: Express Scripts, Inc., CVS Health Corporation, Healthcare stocks news, Stocks on the move, Read m...
Source: SeekingAlpha
Date: May, 11 2018 15:31
Express Scripts Statement on Administration's Comments on Drug Pricing
ST. LOUIS , May 11, 2018 /PRNewswire/ -- Express Scripts (NASDAQ: ESRX) released the following statement in response to the Administration's announcement today on prescription drug costs: "President Trump rightly recognizes drug companies charge way too much, and their price...
Source: PR Newswire
Date: May, 11 2018 14:58
Keeping It Simple On The Short Side
Welcome to Editor's Notes! I aim to sort through the ideas we publish each day and highlight a few that may be of interest to readers, along with comments that may add a helpful gloss. If you have thoughts, comment below or send me a direct message and let me know what you think. Your fe...
Source: SeekingAlpha
Date: May, 11 2018 13:20
Trump to unveil drug pricing plan
Healthcare investors will be looking for direction today as President Trump gives a highly anticipated speech about drug prices. More news on: CVS Health Corporation, Rite Aid Corporation, Walgreens Boots Alliance, Inc., Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: May, 11 2018 03:18

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-1773.5976.3576.9273.5156,019,727
2017-02-0268.7366.6968.8365.828,891,702
2017-02-0168.6569.1169.151968.013,597,957
2017-01-3167.7868.8868.8967.304,226,880
2017-01-3067.5468.1168.17467.034,805,540

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-14584,4851,572,25037.1751Short
2018-08-13268,449811,77833.0693Cover
2018-08-10881,4032,690,18032.7637Cover
2018-08-09932,9314,434,59421.0376Cover
2018-08-081,071,2805,207,94720.5701Cover

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on ESRX.


About Express Scripts Holding Co. (NASDAQ: ESRX)

Logo for Express Scripts Holding Co. (NASDAQ: ESRX)

Not available

 

Contact Information

 

 

Current Management

  • George Paz / President, CEO
  • Edward J. Stiften / CFO, Senior VP
  • Thomas M. Boudreau / Secretary, Senior VP, Chief Legal Officer
  • George Paz / Chairman

Current Share Structure

  • Market Cap: $35,505,140,720 - 05/15/2018
  • Issue and Outstanding: 484,778,000 - 01/31/2012

 


Recent Filings from (NASDAQ: ESRX)

Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 16 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 14 2018
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 08 2018
Notice of exempt solicitation. Definitive material
Filing Type: PX14A6GFiling Source: edgar
Filing Date: May, 04 2018
Notice of exempt solicitation. Definitive material
Filing Type: PX14A6GFiling Source: edgar
Filing Date: May, 02 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 02 2018
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 02 2018
Filing of certain prospectuses and communications in connection with business combination transactions
Filing Type: 425Filing Source: edgar
Filing Date: May, 02 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 25 2018

 

 


Daily Technical Chart for (NASDAQ: ESRX)

Daily Technical Chart for (NASDAQ: ESRX)


Stay tuned for daily updates and more on (NASDAQ: ESRX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: ESRX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in ESRX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of ESRX and does not buy, sell, or trade any shares of ESRX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/